You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Claims for Patent: 10,383,834

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 10,383,834

Title:	Reduced dose intravenous acetaminophen
Abstract:	Described herein are compositions and methods for intravenous administration of acetaminophen at a single dose level of less than about 1000 mg for the treatment or prevention of pain (e.g., postoperative pain) and/or fever.
Inventor(s):	Royal; Mike Allan (San Diego, CA), Breitmeyer; James Bradley (Rancho Santa Fe, CA)
Assignee:	Mallinckrodt Hospital Products IP Limited (Dublin, IE)
Application Number:	15/979,154
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,383,834
Patent Claims:	1. A method of treating pain in a human subject weighing at least 50 kg comprising: administering to the subject an intravenous acetaminophen formulation comprising about 650 mg of acetaminophen; and repeating the administration of the intravenous acetaminophen formulation every four hours; wherein the subject receives a maximum daily dose of less than 4000 mg of acetaminophen per day. 2. The method of claim 1, wherein intravenous acetaminophen formulation is a sterile solution. 3. The method of claim 1, wherein the intravenous acetaminophen formulation is administered to the subject over about 5 minutes to about 30 minutes. 4. The method of claim 1, wherein the intravenous acetaminophen formulation is administered to the subject over about 15 minutes. 5. The method of claim 1, wherein the subject is suffering from acute pain. 6. The method of claim 1, wherein the subject is suffering from postoperative pain. 7. The method of claim 1, wherein the intravenous acetaminophen formulation is a lyophilized powder that is reconstituted prior to administration to the subject. 8. A method of treating fever in a human subject weighing at least 50 kg comprising: administering to the subject an intravenous acetaminophen formulation comprising about 650 mg of acetaminophen; and repeating the administration of the intravenous acetaminophen formulation every four hours; wherein the subject receives a maximum daily dose of less than 4000 mg of acetaminophen per day. 9. The method of claim 8, wherein intravenous acetaminophen formulation is a sterile solution. 10. The method of claim 8, wherein the intravenous acetaminophen formulation is administered to the subject over about 5 minutes to about 30 minutes. 11. The method of claim 8, wherein the intravenous acetaminophen formulation is administered to the subject over about 15 minutes. 12. The method of claim 8, wherein the intravenous acetaminophen formulation is a lyophilized powder that is reconstituted prior to administration to the subject.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.